Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medipal HoldingsMEPDF 81 Earnings per Share (Diluted) is $1.37 as of Mar. 2026. GuruFocus rates MEPDF with a GF Score™ of 81/100 and a GF Value™ of $17.73 (Fairly Valued). The stock has 3 warning signs investors should review. Among 101 Medical Distribution companies, Medipal Holdings ranks better than 51.49% on this metric.
Medipal Holdings's EPS (Basic) for the
three
months ended in Mar. 2026 was $0.16.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was $1.37.
During the past 12 months, Medipal Holdings's average EPS without NRIGrowth Rate was 19.90% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 4.70% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 7.40% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 2.70% per year.
During the past 13 years, Medipal Holdings's highest 3-Year average EPS without NRI Growth Rate was 26.40% per year. The lowest was -29.50% per year. And the median was 2.40% per year.
Medipal Holdings (OTCPK:MEPDF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Medipal Holdings Earnings per Share (Diluted) Related Terms
Medipal Holdings Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings Earnings per Share (Diluted) Chart
MEPDF vs MCK, COR, CAH: Earnings per Share (Diluted) Comparison
For the Medical Distribution subindustry, Medipal Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's PE Ratio distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's PE Ratio falls into.
Medipal Holdings Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Medipal Holdings's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.37
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $1.37 mean?
Medipal Holdings (MEPDF) has a Earnings per Share (Diluted) of $1.37 as of Mar. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Medipal Holdings and its competitors. According to the industry distribution chart, Medipal Holdings ranks #49 out of 101 companies in the Medical Distribution industry, placing it in the top 48.5%.
Is Medipal Holdings' Earnings per Share (Diluted) too high?
Medipal Holdings' current Earnings per Share (Diluted) is $1.37. The Medical Distribution industry median Earnings per Share (Diluted) is 2.60. Medipal Holdings' value of $1.37 is 47.3% below this industry median. Based on the distribution chart, Medipal Holdings ranks #49 out of 101 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Earnings per Share (Diluted) compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #49 out of 101 companies for Earnings per Share (Diluted). This puts Medipal Holdings in the upper half of its industry. The industry median Earnings per Share (Diluted) is 2.60. Medipal Holdings' value of $1.37 is 47.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Distribution company?
The median Earnings per Share (Diluted) among Medical Distribution companies is 2.60, based on 101 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Earnings per Share (Diluted) of $1.37 is 47.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median Earnings per Share (Diluted) is 2.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Earnings per Share (Diluted) is $1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MEPDF) is currently considered Fairly Valued. The stock's GF Value™ is $17.73, compared to a current price of $18.35 — trading 3.5% above its estimated fair value. The current Earnings per Share (Diluted) is $1.37 and 47.3% below the Medical Distribution industry median of 2.60. Medipal Holdings' overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Medipal Holdings (MEPDF), the current Earnings per Share (Diluted) is $1.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MEPDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued.
The current stock price of $18.35 is trading 3.5% above its estimated GF Value™ of $17.73.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MEPDF:
Earnings per Share (Diluted): $1.37
GF Value™: $17.73 vs. price of $18.35 (3.5% above fair value)
Industry Position: 47.3% below the Medical Distribution median (#49 of 101)
No single metric tells the full story. See the MEPDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score
Get the complete analysis for MEPDF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEPDF has been successfully added to your 
